From the ∗Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA

†University of Pittsburgh School of Medicine and Magee-Women's Research Institute, Pittsburgh, PA

‡Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA

§Department of Epidemiology, University of Pittsburgh Graduate School of Public Health

¶Magee-Womens Research Institute, Pittsburgh, PA

∥Alabama Fertility Specialists

∗∗Department of Medicine, University of Alabama at Birmingham, Birmingham, AL

Conflicts of Interest: K.R.H. is on the Speakers bureau for AbbVie, and W.M.G. has received research funds and consulting fees from Hologic and consulting fees from Roche. The other authors declare no conflicts of interest.

Sources of Funding: This study was supported by the Centers for Disease Control and Prevention, Prevention Research Centers (grants 5U48DP001915 to W.M.G. and 5U48DP001918 to H.C.W.) although the administrators of the funds were not involved in the study design, data collection and analysis, writing, or the decision to submit the article for publication.

Disclaimers: The study represents the view of the authors and does not necessarily represent the views of the Centers for Disease Control and Prevention.

Correspondence: Gloria E. Anyalechi, MD, MPH, CDC 1600 Clifton Road, MS US-12-2, Atlanta, GA 30329. E-mail: [email protected].

Received for publication December 3, 2020, and accepted March 29, 2021.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text, and links to the digital files are provided in the HTML text of this article on the journal’s Web site (http://www.stdjournal.com).